B.Pharm Semester 6 Syllabus | New PCI B.Pharm Syllabus 2026

Semester 6 of the new B.Pharm syllabus from the Pharmacy Council of India (NEP-2020) has six core theory courses, one AEC elective slot, two practical courses, one SEC elective slot, one VAC elective slot, and a mandatory internship. The six core theory courses are: Advanced Pharmacognosy, Biopharmaceutics and Pharmacokinetics, Intellectual Property Rights, AI Applications in Pharmaceutical Sciences, Pharmaceutical Analysis, and Pharmaceutical Jurisprudence. The practical courses cover Biopharmaceutics and Pharmacokinetics and Pharmaceutical Analysis. Semester 6 also includes BP612I Internship (Mandatory). Only 1 course shall be selected from each elective slot, as printed in the official syllabus.

Source: Pharmacy Council of India, Syllabus, Bachelor of Pharmacy (B. Pharm) (2026), As per NEP 2020. The syllabus text below is reproduced word for word from the official document.

BP601T Advanced Pharmacognosy (Theory)

Course Objectives: The objectives of this course are to:

Understand reverse pharmacology and integrative approaches in natural drug discovery.
Apply metabolomics and systems biology tools for quality control and bioactivity evaluation of herbal medicines.
Explore modern AI-driven, in-silico, and high-throughput techniques for identification and optimization of natural product leads.
Study validation, safety, and development pathways of herbal leads including preclinical and clinical evaluation.
Understand legal, ethical, and patenting frameworks related to bioprospecting, traditional knowledge protection, and natural product innovation.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Explain reverse pharmacology, traditional knowledge databases, and bioprospecting strategies.
To analyze herbal drugs using metabolomics, spectral libraries, and chemoinformatics tools.
Employ modern in-silico and AI techniques in lead identification and optimization from natural products.
Evaluate preclinical safety, pharmacokinetics, and efficacy of bioactive leads.
Interpret global IP frameworks and develop strategies for patenting herbal products and protecting traditional knowledge.

Unit I

Reverse Pharmacology and Integrative Approaches

Reverse pharmacology and integrative approaches from the AYUSH perspective. Ethnopharmacological approach to bioprospecting. Traditional medicine databases: AYUSH Research Portal, ICMR Standards on Indian Medicinal Plants, TKDL, NAPRALERT, Super Natural, etc. Molecular docking and ADMET screening of bioactives. Concept of adjuvant therapy with herbals in metabolic and non-communicable diseases.

Unit II

Metabolomics and Systems Biology

Introduction to metabolomics and its tools: applications of NMR and HRMS in metabolomics, Metabolomics profiling and dereplication studies, Role of metabolomics in quality control, scientific, validation of traditional claims and pharmacological evaluation, Network pharmacology and systems biology approaches to herbal medicine, Significance of spectral libraries and chemoinformatics databases in drug discovery

Unit III

Modern Techniques in Natural Product Discovery

Role of artificial intelligence (AI), Machine learning and big data in Drug discovery from natural Products. Molecular docking, Virtual Screening and Pharmacophore modelling, Use of Genomic and transcriptomic tools in medicinal plant research, High-throughput screening (HTS) and bioautography.

Unit IV

Validation and Development of Herbal Leads

Bioactivity Guided Fractionation, characterization /Structure Elucidation, Optimization of lead compounds for better efficacy, safety, and stability through SAR and QSAR modelling for semi-synthetic compounds of Salicin, Artemisinin, Piperine, Papaverine and Andrographolides. Preclinical, Clinical Evaluation and New Drug approvals: Testing for toxicity as per OECD guidelines, pharmacokinetics, and bioavailability of herbal products, extracts and lead compounds, assessment of safety and efficacy, clinical trials with or without placebo for clinical endpoints based on assessment of quality of life reporting adverse events if any, filing IND application, NDA submission, Regulatory review and post marketing surveillance.

Unit V

Patenting of Natural Products

Key Terminologies and Concepts: Definitions and distinctions: Patent, Intellectual Property Rights (IPR) Farmers' Rights and Breeders' Rights, Bioprospecting and Biopiracy Patenting Aspects of Natural Products and Traditional Knowledge: Legal frameworks and challenges in patenting natural substances, Traditional Knowledge Digital Library (TKDL) and its role in protecting indigenous knowledge. Role of National Biodiversity Authority in patenting natural products and NAGOYA protocol. Case Studies: Turmeric– U.S. patent on wound healing and its revocation, Neem– Biopiracy issue and patent cancellation.

BP602T Biopharmaceutics and Pharmacokinetics (Theory)

Course Objectives: The objectives of this course are to:

Describe fundamental biopharmaceutics and pharmacokinetic principles governing drug absorption, distribution, metabolism, and excretion.
Analyze the physicochemical and biological factors that determine drug bioavailability, protein binding, and elimination pathways.
Illustrate compartmental pharmacokinetic models, and their evaluations through application of mathematical equations to calculate key parameters.
Design, conduct, and interpret bioavailability, bioequivalence, and in vitro–in vivo correlation studies.
Apply pharmacokinetic principles to optimize dosing regimens—including loading and maintenance doses and steady-state kinetics—and utilize software tools to analyze both linear and non-linear drug kinetics.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Interpret fundamental pharmacokinetic and pharmacodynamic principles and apply them to patient-centered clinical scenarios.
Evaluate the impact of physicochemical and biological variables on drug absorption, distribution, and protein binding in clinical practice.
Differentiate among bioavailability classifications and develop bioequivalence study protocols that comply with international regulatory standards.
Solve pharmacokinetic problems using compartment models by employing numerical techniques
Design optimal dosing regimens, interpret non-linear pharmacokinetic behaviors, and utilize simulation software for PK/PD analysis.

Unit I

Introduction to Biopharmaceutics and pharmacokinetics:

Introduction to various Pharmacokinetic parameters (using Plasma drug Concentration vs Time curve) and Pharmacodynamic parameters and drug delivery index. Absorption; Mechanisms of drug absorption through GIT, Physicochemical, Biological and Dosage form related factors influencing drug absorption though GIT, methods of Assessment of GIT absorption, Distribution Tissue permeability of drugs, binding of drugs, apparent volume of drug distribution, plasma and tissue protein binding of drugs, factors affecting protein-drug binding. Kinetics of protein binding, Clinical significance of protein binding of drugs.

Unit II

Elimination (Metabolism and Elimination):

Drug metabolism and basic understanding of metabolic pathways renal excretion of drugs, factors affecting renal excretion of drugs, renal clearance, non renal routes of drug excretion of drugs

Bioavailability and Bioequivalence:

Definition and Objectives of bioavailability, absolute and relative bioavailability, Introduction to BCS and biopharmaceutical drug disposition classification system, methods of measurement of bioavailability (Plasma data, Urinary excretion data), Protocol for assessment of bioavailability and bioequivalence studies. in-vitro drug dissolution methods (test apparatus I-VII), biorelevant dissolution mediums, in-vitro in-vivo correlations: Concept and Applications, Biowaivers, Methods of enhancement of bioavailability.

Unit III

Pharmacokinetic Models:

Compartment Models: Definition, Basis of classification, Properties of compartment, Advantages and disadvantages of compartment modelling. Kinetic considerations of One compartment open model. (a). Intravenous Injection (Bolus/rapid) (b). Intravenous infusion and (c) Extra-vascular administration. (with emphasis on Curve Fitting, Wagner –Nelson, Loo Riegelman)

Introduction to non - compartment model: Principles, estimation of PK parameters (AUC, AUMC, MRT, MAT statistical moment theory).

Unit IV

Multicompartment models:

Multiple dosage regimen: dosing interval, drug accumulation, loading dose, maintenance dose, PK Parameters Kinetic consideration of two compartment open model (a) Intravenous Injection (Bolus/rapid) and (b) Extra vascular administrations (oral administration). Kinetics of multiple dosing, steady state drug levels, calculation of loading and maintenance doses and their clinical significance. Multiple dosage regimen. Introduction to pharmacokinetic consideration of Modified release drug products.

Unit V

Nonlinear Pharmacokinetics:

Introduction, Reasons for Non-linearity, Michaelis-menton method of estimating parameters, Explanation with example of drugs.

Application of PK software:

Introduction of various in-silico methods for calculating various PK parameters.

BP603T Intellectual Property Rights (Theory)

Course Objectives: The objectives of this course are to:

Introduce the fundamental concepts and types of intellectual property (IP) and highlight their importance in the pharmaceutical and healthcare sectors.
Understand the procedures and legal frameworks related to patent filing, granting, and protection of intellectual property.
Develop awareness of international and national IP laws and treaties, including the TRIPS agreement and Indian Patent Act, and their implications for the pharmaceutical industry.
Provide insights into the management and commercialization of IP, including licensing, technology transfer, and joint ventures.
Familiarize with common IP infringement issues and remedies, using real-world case studies from the pharmaceutical industry to illustrate key principles.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Understand the basic concepts and significance of intellectual property rights with respect to pharmaceutical industries.
Learn the types of intellectual property rights such as patents, copyrights, trademarks, trade secrets.
Understand the procedure for patent filing in India and abroad.
Understand the key provisions of the Indian Patent Act.
Evaluate and understand the strategies for IP management and product commercialization.

Unit I

Introduction to Intellectual Property

Definition and scope of Intellectual Property (IP), Importance and types of IP: Patents, Trademarks, Copyrights and Trade Secrets, Overview of the origin and progression of intellectual property rights in India and internationally, Role of IP in the pharmaceutical industry

Unit II

Patents – Fundamentals and Process

Definition and objectives of patents, Criteria for patentability such as Novelty/innovations, Non-obviousness, Utility, Types of patents and non-patentable inventions in India, Procedure for filing a patent in India, Rights of a patent holder and term of patent protection

Unit III

Patent Laws and Acts

Overview of Indian Patent Act, 1970 (latest amendments and key provisions under the act), TRIPS Agreement and its implications on the Indian pharmaceutical sector, Compulsory licensing, patent opposition, and revocation, Indian pharmaceutical patents: Case studies.

Unit IV

Other Forms of Intellectual Property

Trademarks, Copyrights, Industrial designs: Definition, importance, registration process, Basics and protection in scientific work, Importance and legal framework, Trade secrets and geographical indications in pharma industry

Unit V

IPR Management and Commercialization

Valuation and strategies for commercialization of intellectual property; processes of technology transfer, licensing agreements, and collaborative ventures; issues related to IP infringement and available legal remedies; management practices of IPR in the pharmaceutical industry supported by relevant case studies.

BP604T AI Applications in Pharmaceutical Sciences (Theory)

Course Objectives: The objectives of this course are to:

Introduce applications of artificial intelligence and machine learning across major pharmaceutical disciplines.
Understand the structured data in natural products, medicinal chemistry, formulation science, and manufacturing
Interpret regression and classification models in drug discovery, product performance, and quality monitoring.
Build awareness of predictive modeling for pharmaceutical decision-making.
Understand multivariate analysis in pharmaceutical analytical techniques.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Explain how pharmaceutical data from various domains can be structured for machine learning applications.
Interpret regression and classification models used in natural products and medicinal chemistry.
Analyze predictive modeling approaches in formulation, release, and stability studies.
Evaluate AI applications in manufacturing process monitoring and quality prediction.
Assess analytical modeling and chemometric applications in pharmaceutical quality control.

Unit I

AI in Natural Products & Pharmacognostic Data Modeling

Overview of ML applications in natural products:

• Representation of crude drug data (morphological, microscopic, phytochemical, chromatographic features) • Structuring herbal datasets for predictive modeling • Classification models for authentication of crude drugs (authentic vs adulterated) • Regression models for prediction of secondary metabolite yield • Application of AI in phytochemical screening and prioritization • Herb-drug interaction prediction using database-driven approaches • Limitations of predictive modeling in natural products.

Unit II

AI in Medicinal & Pharmaceutical Chemistry

Overview of the role of AI applications in pharmaceutical chemistry with focus on drug discovery concepts:

• Conversion of molecular structures into numerical descriptors (MW, logP, HBD/HBA, TPSA) • Structured chemical datasets and QSAR modeling • Regression and classification models for predicting biological activity (IC₅₀, solubility, ADMET properties), toxicities. • Virtual screening and lead optimization concepts • Limitations of ML models and importance of chemical reasoning

Unit III

AI in Drug Product Design & Performance Prediction

Overview of AI models across formulation development stages, with emphasis on the applications and limitations:

• Overview of dosage form development and formulation variables • Machine learning in formulation optimization and excipient selection • Regression modeling for solubility and bioavailability enhancement • Time-concentration modeling for drug release interpretation • Stability study design and modeling degradation trends • Shelf-life estimation using regression-based approaches • Practical limitations of extrapolation in formulation science

Unit IV

AI in Process Monitoring & Production Systems

Overview of introduces multivariate analysis in pharmaceutical analytical techniques with focus on the different models and their applications:

• Digital data acquisition in pharmaceutical production • Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) • Correlation analysis for identifying process variability • Logistic regression models for batch pass/fail prediction • Feature importance in process monitoring, predictive maintenance concepts. Ethical and regulatory considerations in automated decision-making, and limitations of predictive models in manufacturing environments.

Unit V

AI in Pharmaceutical Analysis & Chemometrics

Overview of multivariate analysis in pharmaceutical analytical techniques with focus on the different models and their applications:

• Introduction to chemometrics and multivariate analytical data • Spectroscopic data modeling (UV/IR interpretation) • Regression analysis in quantitative pharmaceutical analysis • Chromatographic peak modeling and interpretation • Classification models for genuine vs counterfeit detection • Handling noise and variability in analytical datasets • Limitations of AI models in analytical decision-making

BP605T Pharmaceutical Analysis (Theory)

Course Objectives: The objectives of this course are to:

Understand the interaction of matter with electromagnetic radiation and its application in spectroscopic methods for pharmaceutical drug analysis.
Study the principles, instrumentation, and pharmaceutical applications of electroanalytical techniques such as potentiometry, conductometry, polarography, and amperometry.
Understand and apply various chromatographic and electrophoretic separation techniques used for qualitative and quantitative analysis of drugs.
Impart knowledge of instrumental methods used for accurate qualitative and quantitative analysis of pharmaceutical substances.
Develop the ability to select, optimize, and validate suitable analytical techniques, interpret analytical data.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Explain the theoretical basis of electrochemical methods (potentiometry, conductometry, polarography, amperometry) and spectroscopic techniques (UV-Visible, IR, fluorometry, atomic absorption).
Explain the instruments involved in electroanalytical and spectroscopic methods.
Describe the principles, instrumentation, and applications of various chromatographic and electrophoretic techniques.
Select suitable analytical techniques for specific pharmaceutical analysis requirements.
Analyze, interpret, and report analytical data accurately and draw meaningful conclusions.

Unit I

Electrochemical Methods of analysis

Potentiometry: Electrode potential, electrochemical cell, construction and working of reference and indicator electrodes including membrane electrodes, measurement of potential and pH, potentiometric titrations, methods of detecting end point and Karl Fischer titration.
Conductometry: Introduction, conductivity cell, conductometric titrations and applications.
Polarography: Introduction, residual current, migration current, diffusion current and limiting current, DME, polarographic wave, Ilkovic's equation (Statement Only), and applications.

Unit II

Spectroscopy

Fundamentals of Spectroscopy: Properties of electromagnetic radiation, electromagnetic spectrum.
UV Visible spectroscopy: Beer and Lambert's law, Derivation and deviations. Electronic transitions, chromophores, auxochromes, spectral shifts, solvent effect on absorption spectra, Instrumentation - Sources of radiation, wavelength selectors, sample cells, detectors (Photo tube, Photomultiplier tube, Photo voltaic cell, Silicon Photodiode). Applications - single and multi component analysis of pharmaceuticals.
IR spectroscopy: Introduction, fundamental modes of vibrations in poly atomic molecules, factors affecting vibrations, Instrumentation of dispersive Infrared spectrophotometer (including sample handling Techniques) and FTIR. Pharmaceutical applications.

Unit III

Fluorometric Analysis

Theory, luminescence, factors affecting fluorescence, quenching. Instrumentation and pharmaceutical applications.
Flame Photometry and Atomic Absorption Spectrometry: Theory, nebulisation, flame and flame temperature, interferences, instrumentation and pharmaceutical applications.
Nepheloturbidometry: Principle, instrumentation and applications.

Unit IV

Introduction to Chromatographic Techniques

Principle, various stationary and mobile phases, diverse development and detection techniques and applications of column, paper and thin layer chromatography.
Ion-exchange chromatography: Introduction, principles, types of ions exchange resins, factors affecting ion exchange, methodology and applications.
Gel filtration and affinity chromatography: Principles and applications.
Electrophoresis: Introduction, factors affecting electrophoretic mobility, Techniques of paper, gel, capillary electrophoresis, applications.

Unit V

Gas chromatography: Introduction, theory, instrumentation, derivatization, temperature programming, advantages, disadvantages and applications
High performance liquid chromatography: Introduction, theory, instrumentation, advantages and applications.
HPTLC: Principle, instrumentation and applications.

BP606T Pharmaceutical Jurisprudence (Theory)

Course Objectives: The objectives of this course are to:

Understand the fundamental principles and scope of pharmaceutical legislations governing drug development, manufacture, distribution, and marketing.
Gain comprehensive knowledge of Indian pharmaceutical Acts and Rules, including Drugs and Cosmetics Act, Pharmacy Act, NDPS Act, and related regulations.
Learn the roles, responsibilities, and functions of regulatory authorities involved in regulation and control of pharmaceuticals in India.
Learn the code of pharmaceutical ethics and legal responsibilities in professional pharmacy practice.
Develop the ability to analyse regulatory frameworks, pricing controls, and emerging regulations, and assess their impact on public health, industry compliance, and patient safety.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Demonstrate understanding of major pharmaceutical legislations and explain their relevance in pharmaceutical product development and marketing.
Interpret and apply the provisions of various Indian pharmaceutical Acts and laws in real-world scenarios.
Identify regulatory bodies such as CDSCO, IPC, and state regulatory authorities, and explain their roles in drug approval, manufacturing, and distribution.
Exhibit ethical awareness by applying the code of ethics in professional pharmaceutical practices.
Critically analyze regulatory frameworks and assess their impact on public health, industry operations, and compliance requirements.

Unit I

Drugs and Cosmetics Act, 1940 and its rules 1945: Objectives, Definitions, Legal definitions of schedules to the Act and Rules, CDSCO guidelines for Import & export of Pharmaceuticals Manufacture of drugs – Prohibition of manufacture and sale of certain drugs, Conditions for grant of license and conditions of license for manufacture of drugs, Manufacture of drugs for test, examination and analysis, manufacture of new drug, loan license and repacking license.

Unit II

Drugs and Cosmetics Act, 1940 and its rules 1945.

• Detailed study of Schedule G, H, H1, M, N, P, T, U, V, X, Y, Sch F, Part XII B.

• Sale of Drugs – Wholesale, Retail sale and Restricted license. Offences and penalties

• Labeling & packing of drugs- General labeling requirements and specimen labels for drugs and cosmetics, List of permitted colors. Offences and penalties.

• Administration of the Act and Rules – Drugs Technical Advisory Board, Central drugs Laboratory, Drugs Consultative Committee, Government drug analysts, Licensing authorities, controlling authorities, Drugs Inspectors

Unit III

• Pharmacy Act –1948: Objectives, Definitions, Pharmacy Council of India; its constitution and functions, Education Regulations including ER20, State and Joint state pharmacy councils; constitution and functions, Registration of Pharmacists, Offences and Penalties

• Medicinal and Toilet Preparation Act –1955: Objectives, Definitions, Licensing, Manufacture In bond and Outside bond, Export of alcoholic preparations, Offences and Penalties.

• Narcotic Drugs and Psychotropic substances Act-1985 and Rules: Objectives, Definitions, Authorities and Officers, Constitution and Functions of narcotic & Psychotropic Consultative Committee, National Fund for Controlling the Drug Abuse, Prohibition, Control and Regulation, opium poppy cultivation and production of poppy straw, manufacture, sale and export of opium, Offences and Penalties

• Study of Salient Features of Drugs and Magic Remedies Act and its rules: Objectives, Definitions, Prohibition of certain advertisements, Classes of Exempted advertisements, Offences and Penalties

Unit IV

• Prevention of Cruelty to animals Act-1960: Objectives, Definitions, Institutional Animal Ethics Committee, CCSEA guidelines for Breeding and Stocking of Animals, Performance of Experiments, Transfer and acquisition of animals for experiment, Records, Power to suspend or revoke registration, Offences and Penalties

• National Pharmaceutical Pricing Authority: Drugs Price Control Order (DPCO)- 2013. Objectives, Definitions, Sale prices of bulk drugs, Retail price of formulations, Retail price and ceiling price of scheduled formulations, National List of Essential Medicines (NLEM).

Unit V

• Pharmaceutical Legislations – A brief review, Introduction, Study of drugs enquiry committee, Health survey and development committee, Hathi committee and Mudaliar committee

• Code of Pharmaceutical ethics: Definition, Pharmacist in relation to his job, trade, medical profession and his profession,

• Medical Termination of Pregnancy Act

• Brief Introduction to Right to Information Act

• Introduction New Drugs and Clinical Trials Rules, 2019 and amendments.

• Cosmetic rules 2020

• Regulatory guidelines on similar biologics.

• Overview of Medical Device Regulations, Guidelines on Probiotics, Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016

BP607T AEC Elective Courses (Choose Any One)

This is an elective course slot. One course shall be selected from the list. The six options are:

BP607T AEC1: Green Chemistry
BP607T AEC2: Materiovigilance and Hemovigilance
BP607T AEC3: Scientific Writing
BP607T AEC4: Drug Store and Business Management
BP607T AEC5: Career Building in Cultivation of Medicinal Plants
BP607T AEC6: Active Pharmaceutical Ingredients and Excipient Sciences

Note: The syllabi for these elective subjects are given in the appendix of the official PCI syllabus document. See the full elective syllabi on the appendix page of this section: B.Pharm Elective Courses Appendix.

BP608P Biopharmaceutics and Pharmacokinetics (Practical)

Course Objectives: The objectives of this course are to:

Understand the dissolution profiles of pharmaceutical formulations using various media and conditions.
Apply in vitro and ex vivo techniques to assess drug absorption, dissolution, and bioavailability.
Interpret pharmacokinetic parameters using plasma and urinary excretion data.
Establish in vitro–in vivo correlation (IVIVC) for drug products based on experimental datasets.
Utilize software tools to simulate and analyze pharmacokinetic and pharmacodynamic data.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Explain the fundamental concepts, types, and applications of NDDS in modern therapeutics and precision medicine.
Design and prepare advanced drug delivery systems such as orodispersible tablets, bilayer tablets, osmotic systems, microspheres, microcapsules, buccal/sublingual dosage forms, transdermal patches, gastroretentive systems, and lipid-based carriers.
Select appropriate excipients and techniques for the development of NDDS considering drug properties, patient needs, and target site requirements.
Perform evaluation and quality control tests for novel formulations to ensure efficacy, stability, and patient compliance.
Integrate NDDS strategies into precision medicine frameworks to optimize dosing, therapeutic targeting, and individualized treatment plans.

Note: The course outcomes printed under BP608P in the official document describe Novel Drug Delivery Systems (NDDS), while the course objectives and practical list are on biopharmaceutics and pharmacokinetics. They are reproduced here exactly as printed.

List of Practical:

To calculate MRT from the given data.
To assess the effect of protein binding of a drug
To report relative bioavailability of given drug product using urinary excretion data
To report relative bioavailability of given drug product using plasma data
Establish IVIVC from the given in vitro and in vivo data.
To calculate pharmacokinetic parameters of a drug using given plasma level data.
To report bioequivalence of drug products using given urinary excretion data administered
To calculate absorption rate constant, elimination rate constant and elimination half-life of given excretion data by sigma minus method.
To calculate absorption rate constant, elimination rate constant and elimination half-life of the given drug data administered by IV bolus injection represented by one compartment model.
To calculate the absorption rate constant by using curve fitting method.
To calculate various pharmacokinetic parameters using in silico methods.

*PCI recommended software's shall be used for performing experiments.

BP609P Pharmaceutical Analysis (Practical)

Course Objectives: The objectives of this course are to:

Understand the fundamental principles behind various analytical techniques including titrations, spectrophotometry, fluorimetry, flame photometry, and chromatography.
Develop proficiency in performing quantitative and qualitative analyses of pharmaceutical compounds using classical and instrumental methods.
Learn to operate and maintain laboratory instruments such as potentiometers, conductometers, spectrophotometers, fluorimeters, flame photometers, and chromatographic systems.
Apply appropriate analytical techniques for specific analytical challenges and interpretation, including single and multi-component assays, identification of functional groups, and separation of mixtures.
Learn good laboratory practices and safety protocols in handling chemicals and operating instruments.

Course Outcomes (CO): Upon successful completion of this course, the students will be able to:

Perform accurate titrations (potentiometric and conductometric) to determine the endpoint of acid-base reactions.
Determine absorption maxima, perform assays, and analyze multi-component formulations using spectrophotometric and colorimetric techniques.
Identify functional groups in compounds using FTIR spectroscopy and conduct quantitative analysis using fluorimetry and flame photometry.
Separate and analyze mixtures of compounds using paper chromatography, thin-layer chromatography (TLC), gas-liquid chromatography (GLC), high-performance liquid chromatography (HPLC), and high-performance thin-layer chromatography (HPTLC).
Interpret spectral and chromatographic data to identify compounds and quantify analytes.

List of Practical (Minimum 12 experiments must be performed):

Determination of the endpoint of a acid base titration by potentiometric method.
Determination of end point of acid base titrations by conductometry.
Determination of absorption maxima and effect of solvents on absorption maxima of organic compounds
Assay of APIs by colorimetry.
Assay of single component by UV- Spectrophotometer.
Simultaneous estimation of multicomponent formulations by UV spectrophotometer.
Identification of various functional groups in official compounds by FTIR as per IP.
Assay of quinine sulphate by fluorimetry
Determination of quenching effect by fluorimetry
Assay of sodium chloride by flame photometry
Assay of potassium chloride by flame photometry
Determination of chlorides and sulphates by nephelo turbidometry
Separation of amino acids by paper chromatography
Separation of mixture of components by thin layer chromatography
Demonstration experiment on GC
Determination of official compounds by HPLC (anyone)
Demonstration experiment on HPTLC.

BP610P SEC Elective Courses (Choose Any One)

This is an elective course slot. One course shall be selected in each elective. The three options are:

BP610P SEC1: Computer-Aided Drug Design
BP610P SEC2: Analytical Method Development and Validation
BP610P SEC3: Principles of Preclinical Studies

BP611P VAC Elective Courses (Choose Any One)

This is an elective course slot. One course shall be selected from the list. The two options are:

BP611P VAC1: Professional Skills
BP611P VAC2: Process Analytical Technology (PAT) and QbD in Formulation Science

BP612I Internship (Mandatory)

BP612I Internship is a mandatory internship course listed in Semester 6 of the official syllabus, with course type CORE. The official document notes: Refer section 22 of Regulation. No detailed syllabus text is printed for this course in the document.

Source: Syllabus, Bachelor of Pharmacy (B. Pharm) (2026), As per NEP 2020, Pharmacy Council of India. Syllabus text reproduced word for word from the official document.